Immunomodulation by commensal and probiotic bacteria
- PMID: 20450286
- DOI: 10.3109/08820131003667978
Immunomodulation by commensal and probiotic bacteria
Abstract
Over the past decade there has been an increasing awareness of the role played by commensal bacteria in modulating mucosal immune responses and as a consequence there is now great interest in the therapeutic potential of probiotics and other bacteria based strategies for a range of immune disorders. Here we review current understanding of the mechanisms underlying the immunomodulatory actions of commensal and probiotic bacteria and probiotic organisms. We discuss prominent cell types involved in transducing signals from these bacteria, including epithelial cells, dendritic cells and T regulatory cells. We also draw attention to emerging data indicating interplay between the gut microbiota, enteric neurons and the immune system. There is a focus on the specific aspects of bacteria-host interactions that may influence the ability of a specific organism to confer potentially beneficial changes in immune responses. It is clear that there is still much to learn regarding the determinants of the diverse immune responses elicited by different bacterial strains by building on our current knowledge in these areas it may be possible to design clinically effective, bacteria based strategies to maintain and promote health.
Similar articles
-
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.Immunol Lett. 2004 May 15;93(2-3):97-108. doi: 10.1016/j.imlet.2004.02.005. Immunol Lett. 2004. PMID: 15158604 Review.
-
Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.Int J Med Microbiol. 2010 Jan;300(1):63-73. doi: 10.1016/j.ijmm.2009.08.006. Epub 2009 Oct 13. Int J Med Microbiol. 2010. PMID: 19828372 Review.
-
Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917.Nutr Rev. 2010 Aug;68(8):459-64. doi: 10.1111/j.1753-4887.2010.00305.x. Nutr Rev. 2010. PMID: 20646223 Review.
-
Inflammatory bowel disease, gut bacteria and probiotic therapy.Int J Med Microbiol. 2010 Jan;300(1):25-33. doi: 10.1016/j.ijmm.2009.08.004. Epub 2009 Oct 2. Int J Med Microbiol. 2010. PMID: 19800289 Review.
-
Clinical evidence for immunomodulatory effects of probiotic bacteria.J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):126-41. doi: 10.1097/MPG.0b013e31817d80ca. J Pediatr Gastroenterol Nutr. 2009. PMID: 19179874 Review.
Cited by
-
Feasibility of Using Seaweed (Gracilaria coronopifolia) Synbiotic as a Bioactive Material for Intestinal Health.Foods. 2019 Nov 27;8(12):623. doi: 10.3390/foods8120623. Foods. 2019. PMID: 31783694 Free PMC article.
-
Probiotic Lactobacillus Strains Stimulate the Inflammatory Response and Activate Human Macrophages.J Immunol Res. 2017;2017:4607491. doi: 10.1155/2017/4607491. Epub 2017 Jul 5. J Immunol Res. 2017. PMID: 28758133 Free PMC article.
-
Gut Lactococcus garvieae promotes protective immunity to foodborne Clostridium perfringens infection.Microbiol Spectr. 2024 Oct 3;12(10):e0402523. doi: 10.1128/spectrum.04025-23. Epub 2024 Aug 27. Microbiol Spectr. 2024. PMID: 39190634 Free PMC article.
-
Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability.Br J Nutr. 2013 Jul 14;110(1):1-10. doi: 10.1017/S0007114512004813. Epub 2012 Dec 11. Br J Nutr. 2013. PMID: 23228631 Free PMC article.
-
A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life.Int J Colorectal Dis. 2013 Mar;28(3):349-58. doi: 10.1007/s00384-012-1552-1. Epub 2012 Aug 12. Int J Colorectal Dis. 2013. PMID: 22885882 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous